课题基金 / 基金详情

AAV-vectored immunoprophylaxis for the prevention and treatment of infectious diseases

AAV-vectored immunoprophylaxis for the prevention and treatment of infectious diseases
AAV 载体免疫预防用于预防和治疗传染病
批准号：
478670
负责人：
Wootton Sarah
金额：
$55.45万
依托单位：
Avamab Pharma Inc. (Calgary, Alberta)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2028-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=478670&lang=en
关键词：
Adeno-Associated Virus (Aav) Alternative Vaccine Platform Anti-Drug Antibodies Emerging Infectious Diseases Immune Response To Aav Immunoprophylaxis Large Animal Models Monoclonal Antibody Recrudescence Who Priority Pathogens

项目摘要

项目成果

Wootton Sarah的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Adeno-associated virus (AAV)-mediated expression of pathogen specific, broadly protective monoclonal antibodies (mAb) has been demonstrated to provide protection against a variety of infectious diseases in a range of animal models and is now being tested
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AAV-vectored immunoprophylaxis for the prevention and treatment of infectious diseases
Development of an AAV gene therapy approach for the treatment of surfactant protein B deficiency
  • 批准号：
    402525
  • 项目类别：
    Operating Grants
  • 资助金额：
    $34.55万
  • 财政年份：
    2019
  • 负责人：
    Wootton Sarah
  • 依托单位：
    University of Guelph
CSV2020: The 3rd Symposium of the Canadian Society for Virology
  • 批准号：
    411998
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $0.73万
  • 财政年份：
    2019
  • 负责人：
    Wootton Sarah
  • 依托单位：
    University of Guelph
Clinical Advancement of an AAV Lung Gene Therapy Platform for the Treatment of Monogenic Lung Diseases
  • 批准号：
    415632
  • 项目类别：
    Operating Grants
  • 资助金额：
    $20.46万
  • 财政年份：
    2019
  • 负责人：
    Wootton Sarah
  • 依托单位：
    University of Guelph